A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
Latest Information Update: 03 Nov 2021
At a glance
- Drugs UCN 01 (Primary) ; Prednisone
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 02 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.